The use of levo-carnitine in children with renal disease: A review and a call for future studies

Pediatric Nephrology

Volumn 21, Issue 3, 2006, Pages 308-317

  Belay, Brook ^a   Esteban Cruciani, Nora ^b   Walsh, Christine A ^b   Kaskel, Frederick J ^b  

^a TEMPLE UNIVERSITY   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Anemia; Cardiac disease; Carnitine deficiency; Children; Kidney disease

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; CARNITINE; CHOLESTEROL; ESSENTIAL AMINO ACID; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; RECOMBINANT ERYTHROPOIETIN; TRIACYLGLYCEROL;

AMINO ACID BLOOD LEVEL; ANEMIA; ANTIOXIDANT ACTIVITY; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARNITINE DEFICIENCY; CELL PROTECTION; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; ECHOCARDIOGRAPHY; ENZYME ASSAY; EXERCISE TOLERANCE; FATIGUE; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEMATOCRIT; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; HYPERLIPOPROTEINEMIA TYPE 4; HYPOTENSION; INBORN ERROR OF METABOLISM; INTERMETHOD COMPARISON; KIDNEY DISEASE; KIDNEY FAILURE; LIPID METABOLISM; LOW DRUG DOSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; SEX DIFFERENCE; SPECTROPHOTOMETRY; TANDEM MASS SPECTROMETRY; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; UREMIA; URINARY EXCRETION;

ANEMIA; CARNITINE; CHILD; DYSLIPIDEMIAS; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; STEREOISOMERISM; VITAMIN B DEFICIENCY;

EID: 33244487237     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-005-2085-4     Document Type: Review

References (80)

1. Matera M, Bellinghieri G, Constantino G, Santoro D, Calavani M, Savica V (2003) History of L-carnitine: Implications for renal disease. J Renal Nutr 13:2-14
2. Bremer J (1983) Carnitine - metabolism and functions. Physiol Rev 63:1420-1480
3. Fraenkel G, Friedman S (1957) Carnitine. Harris RS, Marrian GF, Thimann DV (eds) Vitamins and hormones. Academic, New York, pp 73-118
4. Kaneko T, Yoshida R (1962) On the absolute configuration of L-carnitine. Bull Chem Soc Jpn 35:1153-1155
5. Labadie J, Dunn WA, Aronson NN Jr. (1976) Hepatic synthesis of carnitine from protein-bound trimethyllysine. Biochem J 160:85-96
6. Colquhoun A (1998) Induction of apoptosis by polyunsaturated fatty acids and its relationship to fatty acid inhibition of carnitine palmitoyltransferase I activity in Hep2 cells. Biochem Mol Biol Int 45:331-336
7. Brass EP, Beyerinck RA (1988) Effects of propionate and carnitine on the hepatic oxidation of short- and medium-chain-length fatty acids. Biochem J 250:819-825
8. Mister M, Noris M, Szymczuk J, Azzollini N, Aiello S, Abbate M, Trochimowicz L, Gagliardini E, Arduini A, Perico N, Remuzzi G (2002) Propionyl-L-carnitine prevents renal function deterioration due to ischemia/reperfusion. Kidney Int 61:1064-1078
9. Loster H, Keller T, Grommisch J, Grunder W (1999) Effects of L-carnitine and its acetyl and propionyl esters on ATP and PCr levels of isolated rat hearts perfused without fatty acids and investigated by means of 31P-NMR spectroscopy. Mol Cell Biochem 200:93-102
10. Rebouche CJ, Engel AG (1983) Kinetic compartmental analysis of carnitine metabolism in the dog. Arch Biochem Biophys 220:60-70
11. Friolet R, Hoppeler H, Krahenbuhl S (1994) Relationship between the coenzyme A and the carnitine pools in human skeletal muscle at rest and after exhaustive exercise under normoxic and acutely hypoxic conditions. J Clin Invest 94:1490-1495
12. DiMauro S, DiMauro PM (1973) Muscle carnitine palmityltransferase deficiency and myoglobinuria. Science 182:929-931
13. Bank WJ, DiMauro S, Bonilla E, Capuzzi DM, Rowland LP (1975) A disorder of muscle lipid metabolism and myoglobinuria. Absence of carnitine palmitoyl transferase. N Engl J Med 292:443-449
14. Winter SC, Buist NR (2000) Cardiomyopathy in childhood, mitochondrial dysfunction, and the role of L-carnitine. Am Heart J [Suppl] 139:S63-S69
15. Iacobazzi V, Pasquali M, Singh R, Matern D, Rinaldo P, Amat di San Filippo C, Palmieri F, Longo N (2004) Response to therapy in carnitine/ acylcarnitine translocase (CACT) deficiency due to a novel missense mutation. Am J Med Genet A 126:150-155
16. Pierpont ME, Breningstall GN, Stanley CA, Singh A (2000) Familial carnitine transporter defect: A treatable cause of cardiomyopathy in children. Am Heart J 139:S96-S106
17. Petrykowski WV, Ketelsen WP, Schmidt-Sommerfeld E, Penn D, Sawicka E, Struck E, Lehnert W, Haap K, Strassburg HM (1985) Primary systemic carnitine deficiency under successful therapy: Clinical, biochemical, ultrahistochemical and renal clearance studies. Clin Neuropath 4:63-71
18. Scholte HR, Rodrigues Pereira R, de Jonge PC, Luyt-Houwen IE, Hedwig M, Verduin M, Ross JD (1990) Primary carnitine deficiency. J Clin Chem Clin Biochem 28:351-357
19. Helton E, Darragh R, Francis P, Fricker FJ, Jue K, Koch G, Mair D, Pierpont ME, Prochazka JV, Linn LS, Winter SC (2000) Metabolic aspects of myocardial disease and a role for L-carnitine in the treatment of childhood cardiomyopathy. Pediatrics 105:1260-1270
20. Tein I (2002) Role of carnitine and fatty acid oxidation and its defects in infantile epilepsy. J Child Neurol [Suppl] 17: S57-S82
21. Winter SC, Szabo-Aczel S, Curry CJ, Hutchinson HT, Hogue R, Shug A (1987) Plasma carnitine deficiency. Clinical observations in 51 pediatric patients. Am J Dis Child 141:660-665
22. Kurtin PS (1990) Carnitine metabolism and usage in chronic dialysis patients. Semin Dial 3:166-170
23. Savica V, Bellinghieri G, Di Stefano C, Corvaja E, Consolo F, Corsi M, Maccari F, Spagnoli LG, Villaschi S, Palmieri G (1983) Plasma and muscle carnitine levels in hemodialysis patients with morphological-ultrastructural examination of muscle samples. Nephron 34:232-236
24. Moorthy AV, Rosenblum M, Rajaram R, Shug AL (1983) A comparison of plasma and muscle carnitine levels in patients on peritoneal or hemodialysis for chronic renal failure. Am J Nephrol 3:205-208
25. Hoppel C (2003) The role of carnitine in normal and altered fatty acid metabolism. Am J Kidney Dis 41 [Suppl 4]:S4-S12
26. Smogorzewski M, Perna AF, Borum PR, Massry SG (1988) Fatty acid oxidation in the myocardium: Effects of parathyroid hormone and CRF. Kidney Int 34:797-803
27. Schmidt-Sommerfeld E, Werner D, Penn D (1988) Carnitine plasma concentrations in 353 metabolically healthy children. Eur J Pediatr 147:356-360
28. Deufel T (1990) Determination of L-carnitine in biological fluids and tissues. J Clin Chem Clin Biochem 28:307-311
29. Barns RJ, Bowling FG, Brown G, Clague AE, Thompson A (1991) Carnitine in dried blood spots: A method suitable for neonatal screening. Clinica Chimica Acta 197:27-34
30. Chace DH, Pons R, Chiriboga CA, McMahon DJ, Tein I, Naylor EW, De Vivo D (2003) Neonatal blood carnitine concentrations: Normative data by electrospray tandem mass spectrometry. Pediatr Res 53:823-829
31. Gloggler A, Bulla M, Puchstein C, Gulotta F (1988) Plasma and muscle carnitine in healthy and hemodialyzed children. Child Nephrol Urol 9:277-282
32. Chalmers RA, Roe CR, Stacey TE, Hoppel CL (1984) Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: Evidence for secondary insufficiency of l-carnitine. Pediatr Res 18:1325-1328
33. Mamoulakis D, Galanakis E, Dionyssopoulou E, Evangeliou A, Sbyrakis S (2004) Carnitine deficiency in children and adolescents with type 1 diabetes. J Diabetes Complications 18:271-274
34. Brass EP (1995) Pharmacokinetic considerations for the therapeutic use of carnitine in hemodialysis patients. Clin Ther 17:176-185
35. Rebouche CJ, Engel AG (1984) Kinetic compartmental analysis of carnitine metabolism in the human carnitine deficiency syndromes. J Clin Invest 73:857-867
36. Evans AM, Faull R, Fornasini G, Lemanowics EF, Longo A, Pace S, Nation RL (2000) Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis. Clin Pharmacol Ther 68:238-249
37. Gusmano R, Oleggini R, Perfumo F (1981) Plasma carnitine concentrations and dyslipidemia in children on maintenance hemodialysis. J Pediatr 3:429-432
38. Bartel LL, Hussey JL, Shrago E (1982) Effect of dialysis on serum carnitine, free fatty acids, and triglyceride levels in man and the rat. Metabolism 31:944-947
39. Debska-Slizien A, Kawecka A, Wofnarowski K, Prajs J, Malgorzewicz S, Kunicka D, Zdrojewski Z, Lysiak-Szydlowska W, Lipinski J, Rutkowski (2000) Correlation between plasma carnitine, muscle carnitine and glycogen levels in maintenance hemodialysis patients. Int J Artif Organs 23:90-96
40. Vacha GM, Corsi M, Giorcelli G, D'Iddio S, Maccari F (1985) Serum and muscle L-carnitine levels in hemodialyzed patients during and after long-term L-carnitine treatment. Curr Ther Res 37:505-516
41. Bellinghieri G, Savica V, Mallamace A (1983) Correlation between increased serum and tissue L-carnitine levels and improved muscle symptoms in hemodialyzed patients. Am J Clin Nutr 38:523-531
42. Evans A (2003) Dialysis-related carnitine disorder and levocarnitine pharmacology. Am J Kidney Dis 41 [Suppl 4]:S13-S26
43. Bernardini I, Rizzo WB, Dalakas M, Bernar J, Gahl WA (1985) Plasma and muscle free carnitine deficiency due to renal Fanconi syndrome. J Clin Invest 75:1124-1130
44. Gahl WA, Bernardini I, Dalakas M, Rizzo WB, Harper GS, Hoeg JM, Hurko O, Bernar J (1988) Oral carnitine therapy in children with cystinosis and renal Fanconi syndrome. J Clin Invest 81:549-560
45. Gahl WA, Bernardini IM, Dalakas MC, Markello TC, Krasnewich DM, Charnas LR (1993) Muscle carnitine repletion by long-term carnitine supplementation in nephropathic cystinosis. Pediatr Res 34:115-119
46. Asami T, Yanagihara T, Tomisawa S, Hayakawa H, Uchiyama M (1996) Serum carnitine concentrations in different glomerular diseases with normal renal function. Nippon Jinzo Gakkai Shi 38:229-232
47. Labonia WD, Morelli OH Jr, Gimenez MI, Freuler PV, Morelli OH (1987) Effects of L-carnitine on sodium transport in erythrocytes from dialyzed uremic patients. Kidney Int 32:754-759
48. Donatelli M, Terrizzi C, Zumro G, Russo V, Bucalo M, Scarpinaro A (1987) Effects of L-carnitine on chronic anemia and adenosine triphosphate concentration in hemodialyzed patients. Curr Ther Res 41:620-624
49. Arduini A, Rossi M, Mancinelli G, Belfiglio M, Scurti R, Radatti G, Shohet SB (1990) Effect of L-carnitine and acetyl-L-carnitine on the human erythrocyte membrane stability and deformability. Life Sci 47:2395-2400
50. Galluci MT, Lubrano R, Meloni C, Morosetti M, Manca di Villahermosa S, Scoppi P, Palombo G, Castello MA, Casciani CU (1999) Red blood cell membrane lipid peroxidation and resistance to erythropoietin in hemodialysis patients. Clin Nephrol 52:239-245
51. Golper TA, Goral S, Becker BN, Langman CB (2003) L-carnitine treatment of anemia. Am J Kidney Dis 41 [Suppl 4]:S27-S34
52. Hurot JM, Cucherat M, Haugh M, Fouque D (2002) Effects of L-carnitine supplementation in maintenance hemodialysis patients: A systematic review. J Am Soc Nephrol 13:708-714
53. Eknoyan G, Latos DL, Lindberg J (2003) Practice recommendations for the use of L-carnitine in dialysis-related carnitine disorder. National kidney foundation. Carnitine consensus conference. Am J Kidney Dis 41:868-876
54. Lilien MR, Duran M, Quak JM, Frankhuisen JJ, Schroder CH (2000) Oral L-carnitine does not decrease erythropoietin requirement in pediatric dialysis. Pediatr Nephrol 15:17-20
55. Berard E, Iordache A (1992) Effect of low doses of L-carnitine on the response to recombinant human erythropoietin in hemodialyzed children: about two cases. Nephron 62:368-369
56. Schroder CH, European Pediatric Peritoneal Dialysis Working Group (2003) The management of anemia in pediatric peritoneal dialysis patients. Guidelines by an ad hoc European committee. Pediatr Nephrol 18:805-809
57. Siliprandi N, Di Lisa F, Menabo R (1990) Clinical use of carnitine. Past, present and future. Adv Exp Med Biol 272:175-181
58. Lacour B, Di Giulio S, Chanard J, Ciancioni C, Haguet M, Lebkiri B, Basile C, Drueke T, Assan R, Funch-Brentano JL (1980) Carnitine improves lipid anomalies in haemodialysis patients. Lancet 2:763-764
59. Bohles H, Michalk D, von Wendt-Goknur E (1991) Effect of L-carnitine supplementation on lipid metabolism of renal failure, dialysis-dependent children and adolescents. Infusionstherapie 18:224-226
60. Wanner C, Forstner-Wanner S, Shaeffer G, Schollmeyer P, Horl WH (1986) Serum free carnitine, carnitine esters and lipids in patients on peritoneal dialysis and hemodialysis. Am J Nephrol: 206-211
61. Grzegozewska AE, Mariak I, Dobrowolska-Zachwieja A (1999) Continuous ambulatory peritoneal dialysis (CAPD) adequacy influences serum free carnitine level. Int Urol Nephrol 31:533-540
62. Constantin-Teodosiu D, Kirby DP, Short AH, Burden RP, Morgan AG, Greenhaff PL (1996) Free and esterified carnitine in continuous ambulatory peritoneal dialysis patients. Kidney Int 49:158-162
63. Zilleruelo G, Freundlich M, Novak M, Frodada J, Abitbol C, Montane B, Strauss J (1984) Carnitine losses in children on hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD). Pediatr Res 18:373A
64. Zilleruelo G, Freundlich M, Novak M, Frodada J, Abitbol C, Montane B, Strauss J (1985) Favorable effect of L-carnitine supplementation during hemodialysis. Pediatr Res 19:386A
65. Bacri JL, Lacour B, Tete MJ, Broyer M (1981) Effects of L-carnitine in hemodiaylzed pediatric patients. Kidney Int 20:426
66. Zilleruelo G, Novak M, Hsia SL, Goldberg R, Abitbol C, Monkus E, Strauss J (1989) Effect of dialysate composition on the lipid response to L-carnitine supplementation. Kidney Int 36 [Suppl 27]:S259-S263
67. Gloggler A, Bulla M, Furst P (1989) Effect of low dose supplementation of L-carnitine on lipid metabolism in hemodialyzed children. Kidney Int 36 [Suppl 27]:S256-S258
68. Warady BA, Borum P, Stall C, Millspaugh J, Taggart E, Lum G (1990) Carnitine status of pediatric patients on continuous ambulatory peritoneal dialysis. Am J Nephrol 10:109-114
69. Murakami R, Momota T, Yoshiya K, Yoshikawa N, Nakamura H, Honda M, Ito H (1990) Serum carnitine and nutritional status in children treated with continuous ambulatory peritoneal dialysis. J Pediatr Gastronenterol Nutr 11:371-374
70. Zachwieja J, Duran M, Joles JA, van de Hurk D, Frankhuisen JJ, Donckerwolcke RAMG (1994) Amino acid and carnitine supplementation in haemodialyzed children. Pediatr Nephrol 8:739-743
71. Kosan C, Sever L, Ansoy N, Caliskan S, Kasapcopur O (2003) Carnitine supplementation improves apolipoprotein B levels in pediatric peritoneal dialysis patients. Pediatr Nephrol 18:1184-1188
72. Fritz IB, Arrigoni-Martelli E (1993) Sites of action of carnitine and its derivatives on the cardiovascular system: Interactions with membranes. Trends Pharmacol Sci 14:355-360
73. Sakurabayashi T, Takaesu Y, Haginoshita S, Takeda I, Aoike I, Miyazaki S, Koda Y, Yuasa Y, Sakai S, Suzuki M, Takahashi S, Hirasawa Y, Nakamura T (1999) Improvement of myocardial fatty acid metabolism through L-carnitine administration to chronic hemodialysis patients. Am J Nephrol 19:480-484
74. Matsumoto Y, Motoyoshi S, Ohashi H, Araki H, Tadokoro, Osumi Y, Ito H, Morita H, Amano I (2000) Effects of L-carnitine supplementation on cardiac morbidity in hemodialyzed patients. Am J Nephrol 20:201-207
75. Fagher B, Cederblad G, Monti M, Olsson L, Rasmusen B, Thysell H (1985) Carnitine and left ventricular function in haemodialysis patients. Scand J Clin Lab Invest 45:193-198
76. Ahmad S, Robertson HT, Golper TA, Wolfson M, Kurtin P, Katz LA, Hirschberg R, Nicora R, Ashbrook DW, Kopple JD (1990) Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects. Kidney Int 38:912-918
77. Brass EP, Adler S, Sietsema KE, Hiatt WR, Orlando AM, Amato A (2001) Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients. Am J Kidney Dis 37:1018-1028
78. Topaloglu R, Celiker A, Saatci U, Kilinc K, Bakkaloglu A, Besbas N, Tokel S, Tokel K (1998) Effect of carnitine supplementation on cardiac function in hemodialyzed children. Acta Paediatr Jpn 40:26-29
79. Khoss AE, Steger H, Legenstein E, Proll E, Salzer-Muhar U, Schlemmer M, Balzar E, Wimmer M (1989) L-carnitine therapy and myocardial function in children treated with chronic hemodialysis. Wien Klin Wochenschr 101:17-20
80. Steinman TI, Nissenson AR, Glassock RJ, Dickmeyer J, Mattern WD, Parker TF 3rd, Hull AR (2003) L-carnitine use in dialysis patients: Is national coverage for supplementation justified? What were CMS regulators thinking - or were they? Nephrol News Issues 17:28-36